-
16371-10An anthranilic acid derivative that activates the oxidized (heme-free) form of sGC (EC<sub>50</sub> = 0.5-10 µM in purified bovine lung or crude human corpus cavernosum) by binding to the heme pocket and mimicking its function increases cGMP
-
16371-5An anthranilic acid derivative that activates the oxidized (heme-free) form of sGC (EC<sub>50</sub> = 0.5-10 µM in purified bovine lung or crude human corpus cavernosum) by binding to the heme pocket and mimicking its function increases cGMP
-
11733-1An inhibitor of HIV-1 protease (EC50 = 2.6 nM) commonly used in vivo in combination therapy for HIV-1 infection.
-
11733-5An inhibitor of HIV-1 protease (EC50 = 2.6 nM) commonly used in vivo in combination therapy for HIV-1 infection.
-
10277-1A hybrid molecule of an H2S donor and the NSAID diclofenac that does not cause gastric damage or promote leukocyte adherence to vascular endothelium exhibits efficacy at doses of 10-50 µmole/kg in rat.
-
10277-10A hybrid molecule of an H2S donor and the NSAID diclofenac that does not cause gastric damage or promote leukocyte adherence to vascular endothelium exhibits efficacy at doses of 10-50 µmole/kg in rat.
-
10277-5A hybrid molecule of an H2S donor and the NSAID diclofenac that does not cause gastric damage or promote leukocyte adherence to vascular endothelium exhibits efficacy at doses of 10-50 µmole/kg in rat.
-
10277-50A hybrid molecule of an H2S donor and the NSAID diclofenac that does not cause gastric damage or promote leukocyte adherence to vascular endothelium exhibits efficacy at doses of 10-50 µmole/kg in rat.
-
13045-1A hybrid molecule of an H2S donor and the NSAID indomethacin that does not cause gastric damage or promote leukocyte adherence to vascular endothelium.
-
13045-10A hybrid molecule of an H2S donor and the NSAID indomethacin that does not cause gastric damage or promote leukocyte adherence to vascular endothelium.
-
13045-5A hybrid molecule of an H2S donor and the NSAID indomethacin that does not cause gastric damage or promote leukocyte adherence to vascular endothelium.
-
13045-50A hybrid molecule of an H2S donor and the NSAID indomethacin that does not cause gastric damage or promote leukocyte adherence to vascular endothelium.